As of 2024-12-11, the Relative Valuation of Life Science REIT PLC (LABS.L) is (86.25) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 38.20 GBP, the upside of Life Science REIT PLC based on Relative Valuation is -325.8%.
The range of the Relative Valuation is (72.68) - (86.02) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.7x - 7.5x | 7.1x |
| Forward P/E multiples | 6.3x - 8.1x | 7.9x |
| Fair Price | (72.68) - (86.02) | (86.25) |
| Upside | -290.3% - -325.2% | -325.8% |
| Date | P/E |
| 2024-12-06 | -3.33 |
| 2024-12-05 | -3.31 |
| 2024-12-04 | -3.30 |
| 2024-12-03 | -3.22 |
| 2024-12-02 | -3.22 |
| 2024-11-29 | -3.19 |
| 2024-11-28 | -3.29 |
| 2024-11-27 | -3.34 |
| 2024-11-26 | -3.27 |
| 2024-11-25 | -3.26 |
| 2024-11-22 | -3.22 |
| 2024-11-21 | -3.33 |
| 2024-11-20 | -3.45 |
| 2024-11-19 | -3.45 |
| 2024-11-18 | -3.39 |
| 2024-11-15 | -3.57 |
| 2024-11-14 | -3.64 |
| 2024-11-13 | -3.65 |
| 2024-11-12 | -3.67 |
| 2024-11-11 | -3.70 |
| 2024-11-08 | -3.74 |
| 2024-11-07 | -3.70 |
| 2024-11-06 | -3.67 |
| 2024-11-05 | -3.65 |
| 2024-11-04 | -3.67 |
| 2024-11-01 | -3.67 |
| 2024-10-31 | -3.63 |
| 2024-10-30 | -3.67 |
| 2024-10-29 | -3.69 |
| 2024-10-28 | -3.65 |
| 2024-10-25 | -3.52 |
| 2024-10-24 | -3.50 |
| 2024-10-23 | -3.48 |
| 2024-10-22 | -3.39 |
| 2024-10-21 | -3.39 |
| 2024-10-18 | -3.39 |
| 2024-10-17 | -3.54 |
| 2024-10-16 | -3.52 |
| 2024-10-15 | -3.49 |
| 2024-10-14 | -3.53 |
| 2024-10-11 | -3.43 |
| 2024-10-10 | -3.44 |
| 2024-10-09 | -3.43 |
| 2024-10-08 | -3.43 |
| 2024-10-07 | -3.43 |
| 2024-10-04 | -3.39 |
| 2024-10-03 | -3.48 |
| 2024-10-02 | -3.50 |
| 2024-10-01 | -3.50 |
| 2024-09-30 | -3.39 |